21 insiders have filed at BIIB since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Alexander Susan H | EVP Chief Legal Officer | 61.9k | 0.042% | ||
| Dorsa Caroline | Director | 31.0k | 0.021% | 1 buys $152k | |
| Viehbacher Christopher | President And CEO | 29.9k | 0.02% | ||
| Mcdonnell Michael R | EVP, Chief Financial Officer | 24.3k | 0.016% | ||
| Rowinsky Eric K | Director | 24.3k | 0.016% | 1 buys $101k | |
| Gregory Ginger | EVP, Human Resources | 22.4k | 0.015% | ||
| Murphy Nicole | Head Of Pharm Ops And Tech | 19.6k | 0.013% | 1 buys $1k | |
| Sherwin Stephen A | Director | 13.7k | <0.01% | 1 sells $1.3M | |
| Kramer Robin | Chief Financial Officer | 11.5k | <0.01% | ||
| Izzar Rachid | Head Of Global Product Strat. | 11.0k | <0.01% | 1 sells $300k | |
| Mantas Jesus B | Director | 9.8k | <0.01% | ||
| Hawkins William A | Director | 8.9k | <0.01% | ||
| Singhal Priya | Head Of Development | 8.0k | <0.01% | 14 sells $1.8M | |
| Freire Maria C | Director | 6.8k | <0.01% | ||
| Keeney Adam | Head Of Corporate Development | 5.9k | <0.01% | ||
| Langer Susan | Director | 5.1k | <0.01% | ||
| Grogan Jane | Head Of Research | 4.1k | <0.01% | ||
| Patolawala Monish D | Director | 3.7k | <0.01% | ||
| Minor Lloyd | Director | 2.4k | <0.01% | ||
| Godbout Sean | Chief Accounting Officer | 1.2k | <0.01% | ||
| Pangalos Menelas N | Director |
Full register at boothcheck.com/insiders/BIIB. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.